HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Dey, H. M. Articles by Innis, R. B. Search for Related Content PubMed PubMed Citation Articles by Dey, H. M. Articles by Innis, R. B.

Human Biodistribution and Dosimetry of the SPECT Benzodiazepine Receptor Radioligand Iodine-123-Iomazenil

Section of Nuclear Medicine, Department of Diagnostic Radiology and Department of Psychiatry at the West Haven Veterans Affair Medical Center and Yale University School of Medicine, New Haven, Connecticut
Radiation Internal Dose Information Center, Oak Ridge Institute for Science and Education, Oak Ridge, Tennessee

Correspondence: For correspondence or reprints contact: Holley M. Dey, MD, Nuclear Medicine/115A, Veterans Affairs Medical Center, West Haven, CT 06516.

ABSTRACT

SPECT imaging of the brain with [¹²³]iomazenil has shown avid uptake of the radioligand in a distribution consistent with benzodiazepine receptor binding. The purposes of this study were to measure the whole-body distribution of activity following i.v. administration of [¹²³]iomazenil and to evaluate the resulting organ radiation burdens. Methods: Serial total body scans were obtained in healthy volunteers after thyroid blockade and demonstrated avid brain uptake of radioligand. Results: Abdominal imaging showed significant activity retention with in the urinary and gastrointestinal tracts consistent with excretion via these routes. Absorbed dose to the urinary bladder was calculated to be 0.19 mGy/MBq, to the lower large intestine 0.079 mGy/MBq, to the upper large intestine 0.066 mGy/MBq, and to the thyroid 0.063 mGy/MBq. Conclusion: Thyroid uptake may in part have represented binding to benzodiazepine receptors, since radioligand binding to tissue homogenates prepared from human tyroid showed the presence of benzodiazepine binding sites.

Key Words: iodine-123 iomazenil • dosimetry • benzodiazepine receptor

This article has been cited by other articles:

				S. A. Ross and J. P. Seibyl Research Applications of Selected 123I-Labeled Neuroreceptor SPECT Imaging Ligands J. Nucl. Med. Technol., December 1, 2004; 32(4): 209 - 214. [Abstract] [Full Text] [PDF]

				T. F. Massoud and S. S. Gambhir Molecular imaging in living subjects: seeing fundamental biological processes in a new light Genes & Dev., March 1, 2003; 17(5): 545 - 580. [Full Text] [PDF]

				J. Hatazawa, E. Shimosegawa, T. Satoh, I. Kanno, and K. Uemura Central Benzodiazepine Receptor Distribution After Subcortical Hemorrhage Evaluated by Means of [123I]Iomazenil and SPECT Stroke, December 1, 1995; 26(12): 2267 - 2271. [Abstract] [Full Text]

				C. I. Okocha, F. Kapczinski, N. Lassen, and M. H. Lader Central benzodiazepine receptor imaging and quantitation with single photon emission computerised tomography: SPECT J Psychopharmacol, January 1, 1995; 9(4): 369 - 380. [Abstract] [PDF]